401
Capital Partners Inc. is a Canadian venture capital and private
equity buy-out firm with offices in Oakville, Ontario and Montreal.
401
Capital Partners Inc. was formed by a successful group of entrepreneurs
with the principal goal of acquiring and growing undervalued businesses.
Our equity base is provided entirely by our principals and private
limited partners with investments ranging from $500,000 to $15,000,000
and leveraged buyouts of companies up to $200mm in sales.
Private
Equity
401
Private Equity LLP looks to purchase controlling interests in stable,
profitable businesses in the pharmaceuticals and consumer health
markets. We focus on defensible and stable products and services
that address large existing markets that require strategic promotion
or realignment.
We
are equally interested in:
- Divisional
or corporate divestitures
- Management
buy-outs
- Fragmented
industry consolidations
401
seeks management teams with successful track records and domain
expertise where contribution of capital, structuring experience
and contacts we provide can together maximize shareholder value.
Venture
Capital
401
Ventures LLP's objective is to build high value life sciences and
emerging technology companies that provide consistently superior
returns to both investors and entrepreneurs. To achieve this goal,
we identify, research, fund, and actively support entrepreneurial
endeavors that we believe have the best chance for success in today’s
intensely competitive world.
We
sustain our business model by:
- Focusing
our investments on real technologies with discernible promise
- Leveraging
the strength of our team’s operational backgrounds to actively
foster our portfolio companies’ success using a hands-on
approach
- Connecting
our entrepreneurs with an extensive network of partners and resources
garnered over many years
- Consistently
delivering solid returns to our partners and entrepreneurs
|
